Acuta Capital Partners as of Sept. 30, 2017
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 56 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Immunomedics | 18.6 | $104M | 7.4M | 13.98 | |
| iShares Russell 2000 Index (IWM) | 12.3 | $69M | 465k | 148.18 | |
| SPDR S&P Biotech (XBI) | 8.7 | $49M | 560k | 86.57 | |
| Assembly Biosciences | 6.3 | $35M | 1.0M | 34.92 | |
| Veracyte (VCYT) | 5.2 | $29M | 3.3M | 8.77 | |
| Iovance Biotherapeutics (IOVA) | 4.8 | $27M | 3.4M | 7.75 | |
| Intec Pharma | 4.4 | $24M | 2.7M | 8.95 | |
| IRIDEX Corporation (IRIX) | 3.4 | $19M | 2.0M | 9.37 | |
| Ascendis Pharma A S (ASND) | 3.2 | $18M | 500k | 36.25 | |
| Dbv Technologies S A (DBVT) | 3.0 | $17M | 401k | 42.44 | |
| Zogenix | 2.6 | $14M | 410k | 35.05 | |
| Edge Therapeutics | 2.4 | $13M | 1.3M | 10.73 | |
| Kadmon Hldgs | 2.0 | $11M | 3.3M | 3.35 | |
| Chembio Diagnostics | 1.9 | $11M | 1.7M | 6.20 | |
| Evolent Health (EVH) | 1.7 | $9.5M | 533k | 17.80 | |
| ACADIA Pharmaceuticals (ACAD) | 1.6 | $9.0M | 240k | 37.67 | |
| Viewray (VRAYQ) | 1.4 | $7.7M | 1.3M | 5.76 | |
| Amicus Therapeutics (FOLD) | 1.2 | $6.8M | 451k | 15.08 | |
| Clovis Oncology | 1.2 | $6.6M | 80k | 82.40 | |
| Seattle Genetics | 1.1 | $6.0M | 110k | 54.40 | |
| Johnson & Johnson (JNJ) | 1.1 | $5.9M | 45k | 130.00 | |
| BioCryst Pharmaceuticals (BCRX) | 0.9 | $5.2M | 996k | 5.24 | |
| Invitae (NVTAQ) | 0.9 | $4.9M | 528k | 9.37 | |
| Argenx Se (ARGX) | 0.9 | $4.9M | 216k | 22.61 | |
| CAS Medical Systems | 0.8 | $4.7M | 5.1M | 0.92 | |
| iShares FTSE/Xinhua China 25 Index (FXI) | 0.8 | $4.4M | 100k | 44.04 | |
| Viveve Med | 0.8 | $4.3M | 827k | 5.24 | |
| Nabriva Therapeutics | 0.6 | $3.3M | 400k | 8.19 | |
| Tocagen | 0.6 | $3.1M | 251k | 12.46 | |
| Quotient | 0.5 | $2.8M | 569k | 4.93 | |
| Fennec Pharmaceuticals (FENC) | 0.5 | $2.8M | 250k | 11.09 | |
| Lannett Company | 0.4 | $2.4M | 128k | 18.45 | |
| Alexion Pharmaceuticals | 0.4 | $2.1M | 15k | 140.27 | |
| Rockwell Medical Technologies | 0.4 | $2.1M | 250k | 8.56 | |
| Centene Corporation (CNC) | 0.3 | $1.9M | 20k | 96.75 | |
| Nightstar Therapeutics | 0.3 | $1.9M | 100k | 19.20 | |
| Gogo (GOGO) | 0.3 | $1.6M | 135k | 11.81 | |
| Aimmune Therapeutics | 0.3 | $1.5M | 59k | 24.79 | |
| Combimatrix Corporation *w exp 03/18/2021 | 0.2 | $1.4M | 564k | 2.50 | |
| Alimera Sciences | 0.2 | $1.3M | 974k | 1.35 | |
| Accelr8 Technology | 0.2 | $1.3M | 60k | 22.45 | |
| Evertec (EVTC) | 0.2 | $1.1M | 69k | 15.84 | |
| Portola Pharmaceuticals | 0.2 | $1.1M | 20k | 54.05 | |
| Ra Pharmaceuticals | 0.2 | $1.0M | 72k | 14.60 | |
| Teladoc (TDOC) | 0.2 | $995k | 30k | 33.17 | |
| Glaukos (GKOS) | 0.2 | $990k | 30k | 33.00 | |
| AMAG Pharmaceuticals | 0.2 | $923k | 50k | 18.46 | |
| MiMedx (MDXG) | 0.1 | $832k | 70k | 11.89 | |
| Combimatrix Corporation | 0.1 | $839k | 112k | 7.50 | |
| Mannkind (MNKD) | 0.1 | $760k | 350k | 2.17 | |
| Lexicon Pharmaceuticals (LXRX) | 0.1 | $492k | 40k | 12.30 | |
| Axovant Sciences | 0.0 | $140k | 20k | 6.90 | |
| Otonomy | 0.0 | $57k | 18k | 3.26 | |
| Oncobiologics | 0.0 | $40k | 29k | 1.38 | |
| Oncobiologics Inc *w exp 02/18/201 | 0.0 | $12k | 97k | 0.12 | |
| Oncobiologics Inc *w exp 05/18/201 | 0.0 | $4.8k | 97k | 0.05 |
